Autopsy report · NCT02100150
A Safety and Efficacy Study of NNZ-2566 in Patients With Mild Traumatic Brain Injury (mTBI)
Cause of deathNo reason given
Life of this trial
- Registered 6 months before it started.
- Ran for about 1 year 9 months before it stopped.
- 32 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- Neuren Pharmaceuticals Limited
- Sponsor type
- Industry
- Conditions
- Concussion
- Interventions
- NNZ-2566; Placebo
- Participants
- 32
- Sites
- 1
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.